Analyst Ratings for Asterias Biotherapeutics (AST)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/10/2018 | Raymond James | N/A | Downgrade | Market Perform (Outperform) |
N/A (N/A) |
1.60 (0.95) |
-40.63% | Details |
| 2/22/2018 | B.Riley | N/A | New Coverage | Buy (N/A) |
6.00 (N/A) |
2.05 (0.95) |
-53.66% | Details |
 |
||||||||
|
||||||||
